Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| U21A20136 | Other Grant/Funding Number | The National Natural Science Foundation of China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Post-stroke patients were required to complete a session of robot-assisted training, which involved nine repetitions of 5-meter overground walking (three trials for each of the three controllers) in a rectangular hospital corridor.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Robot gait training group | Experimental | During this study, we will explore which control strategy: Aware Hip Knee Coupling Control (AHKC), Passive control (PC), or fixed compliance control (FCC) may be optimal for post-stroke subjects |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Robot-assisted overground gait training | Device | Post-stroke patients were required to complete a session of robot-assisted training, which involved nine repetitions of 5-meter overground walking (three trials for each of the three controllers). |
| Measure | Description | Time Frame |
|---|---|---|
| Change in 10 Meter Walk Test from baseline gait speed | Gait speed will be assessed by instructing participants to walk at their maximum safe speed. Each participant will start 1 meter before the designated start line and continue walking until 1 meter past the finish line. The time taken to traverse the measured distance will be recorded using a stopwatch to the nearest one hundredth of a second. | Baseline, immediately after intervention |
| Measure | Description | Time Frame |
|---|---|---|
| Change scores of Lower Extremity Fugl-Meyer Assessment (FMA-LE) | The Lower Extremity Fugl-Meyer Assessment (FMA-LE) is a validated, performance-based scale used to evaluate motor function, reflexes, coordination, and movement synergy of the lower limb in stroke patients. The FMA-LE consists of 17 items, each scored on a 3-point ordinal scale (0 = cannot perform, 1 = performs partially, 2 = performs fully), with a total possible score ranging from 0 to 34. Higher scores indicate better lower limb motor function. Assessments will be performed by trained evaluators according to standardized procedures. |
Not provided
Inclusion Criteria:
Stroke patients aged between 18 and 75 years. Patients who are medically stable and able to stand and walk independently for at least 10 meters during rehabilitation.
Stroke event occurred at least 3 months ago Patients with impaired lower limb motor function but with some degree of muscle activity in the lower extremities.
Patients without severe cognitive impairment and capable of understanding and following the treatment protocol.
Patients without severe balance or coordination disorders, able to maintain balance and perform gait training with assistive devices.
Patients without lower limb fractures or other serious skeletal issues affecting the lower limbs.
Patients without severe cardiovascular or other serious illnesses and able to tolerate the intensity and duration of rehabilitation therapy.
Patients willing to participate in the study and able to provide written informed consent.
Exclusion Criteria:
Severe cognitive impairment that prevents the patient from understanding or complying with the treatment protocol.
Severe balance or coordination disorders that prevent the patient from maintaining balance and participating in gait training, even with assistive devices.
Other serious motor disorders, such as abnormal muscle tone or ataxia, which may interfere with the effectiveness of rehabilitation therapy.
Active cardiovascular disease or other serious systemic illnesses that may affect the patient's safety or treatment outcomes.
Lower limb fractures or other serious skeletal issues that may impact the suitability and safety of robot-assisted rehabilitation therapy.
Patients currently receiving other rehabilitation or experimental treatments. Patients with skin ulcers, infections, or other severe skin conditions that may interfere with the use and application of robotic devices.
Unexplained discomfort or pain symptoms that may limit the patient's ability to participate in rehabilitation therapy.
Failure to meet other specific inclusion criteria outlined in the study protocol.
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Shaofeng Zhao | Contact | 86 18898773680 | zhaosf1@163.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Eight affiliated hospital, Sun Yat-Sen University | Recruiting | Shenzhen | Guangzhou | 518033 | China |
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| D051346 | Mobility Limitation |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Baseline, immediately after intervention |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |